116 related articles for article (PubMed ID: 18760600)
1. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
Deng Q; Frie JL; Marley DM; Beresis RT; Ren N; Cai TQ; Taggart AK; Cheng K; Carballo-Jane E; Wang J; Tong X; Waters MG; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2008 Sep; 18(18):4963-7. PubMed ID: 18760600
[TBL] [Abstract][Full Text] [Related]
2. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
Shen HC; Taggart AK; Wilsie LC; Waters MG; Hammond ML; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2008 Sep; 18(18):4948-51. PubMed ID: 18752940
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
[TBL] [Abstract][Full Text] [Related]
4. Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor.
Shen HC; Ding FX; Luell S; Forrest MJ; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Deng Q; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
J Med Chem; 2007 Dec; 50(25):6303-6. PubMed ID: 17994679
[TBL] [Abstract][Full Text] [Related]
5. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).
Tunaru S; Lättig J; Kero J; Krause G; Offermanns S
Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840
[TBL] [Abstract][Full Text] [Related]
6. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
Shen HC; Ding FX; Deng Q; Wilsie LC; Krsmanovic ML; Taggart AK; Carballo-Jane E; Ren N; Cai TQ; Wu TJ; Wu KK; Cheng K; Chen Q; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
J Med Chem; 2009 Apr; 52(8):2587-602. PubMed ID: 19309152
[TBL] [Abstract][Full Text] [Related]
8. Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity.
Peters JU; Kühne H; Dehmlow H; Grether U; Conte A; Hainzl D; Hertel C; Kratochwil NA; Otteneder M; Narquizian R; Panousis CG; Ricklin F; Röver S
Bioorg Med Chem Lett; 2010 Sep; 20(18):5426-30. PubMed ID: 20724150
[TBL] [Abstract][Full Text] [Related]
9. Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists.
van Veldhoven JP; Liu R; Thee SA; Wouters Y; Verhoork SJ; Mooiman C; Louvel J; IJzerman AP
Bioorg Med Chem; 2015 Jul; 23(14):4013-25. PubMed ID: 25737085
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A).
van Veldhoven JP; Blad CC; Artsen CM; Klopman C; Wolfram DR; Abdelkadir MJ; Lane JR; Brussee J; Ijzerman AP
Bioorg Med Chem Lett; 2011 May; 21(9):2736-9. PubMed ID: 21167710
[TBL] [Abstract][Full Text] [Related]
11. GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Taggart AK; Cheng K; Carballo-Jane E; Gerard Waters M; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2009 Apr; 19(8):2121-4. PubMed ID: 19307116
[TBL] [Abstract][Full Text] [Related]
12. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Gharbaoui T; Boatman PD; Sage CR; Chen R; Richman JG; Connolly DT; Semple G
J Med Chem; 2007 Apr; 50(7):1445-8. PubMed ID: 17358052
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
[TBL] [Abstract][Full Text] [Related]
14. Future of GPR109A agonists in the treatment of dyslipidaemia.
Wanders D; Judd RL
Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
[TBL] [Abstract][Full Text] [Related]
16. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
[TBL] [Abstract][Full Text] [Related]
17. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b.
Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Dang HT; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
Bioorg Med Chem Lett; 2007 Dec; 17(23):6619-22. PubMed ID: 17931863
[TBL] [Abstract][Full Text] [Related]
18. The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties.
Imbriglio JE; DiRocco D; Bodner R; Raghavan S; Chen W; Marley D; Esser C; Holt TG; Wolff MS; Taggart AK; Waters MG; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2011 May; 21(9):2721-4. PubMed ID: 21185185
[TBL] [Abstract][Full Text] [Related]
19. GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Holt TG; Wolff MS; Taggart AK; Cheng K; Carballo-Jane E; Waters MG; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4472-4. PubMed ID: 20615702
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
Kamanna VS; Kashyap ML
Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
